http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004052836-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_167f4d21e2fbe2c5dc8fe274b116ed63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6120b44920221f5a3fddac2d48061c52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02f9d8e1097f733b26f91087c5f28045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00c917cdf93c76be481a3f5e8f5b6850
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988693f0be1f55f86dc2d6ec3fb3e0ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e6e71cc271fa252c73f5db9df93e666
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-66
filingDate 2003-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f8751efc2fa4a043cd16637639d7ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6edfb640dde6963b9d60ff537c2e0c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_888ff59af85fc93511843d0871a149d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6dba9bee452059ba3f67790c9b49f1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5716944e3f0181d2a26cc0cea838352
publicationDate 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004052836-A1
titleOfInvention Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
abstract The invention concerns a method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof of general formula (I), characterized in that it consists in reducing an isoxazole derivative of formula (II) in conditions directly resulting in the derivatives of formula (I), or in obtaining at least a lactone of structure (III) in racemic form(s), or a enantiomerically enriched mixture, followed by opening, in basic conditions, in an aprotic or protic solvent, the desired lactone(s) and, optionally, separating the desired form. The invention is useful for preparing in particular (2S, 3R, 4S)-4-hydroxyisoleucine.
priorityDate 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2773624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129650716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67057657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128853787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231128007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127902549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226568726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11440002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231993200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226606953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87964518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87069337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69723392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231993390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87804881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231998996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128189394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128061422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135964628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227710232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55302558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID354197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6570

Total number of triples: 64.